~~<i id='55AFBD546F'><strike id='55AFBD546F'><tt id='55AFBD546F'><pre id='55AFBD546F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

fashion

author：leisure time 2025-09-11 06:21:11 - browse：67555

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： How the drug

focus

explore

knowledge

focus

hotspot

focus

LIONELBONAVENTURE/AFPviaGettyImagesOnTuesday,DukeHealthandMicrosoftannouncedafive-yearpartnershiptha

WSS

Kellogg’s is going to war over Mexico’s nutrition label rules

Meadows told special counsel he could not recall Trump ever declassifying Mar

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

ProMED, early warning system on disease outbreaks, in peril

People can get long Covid without testing positive for virus: Study

Former Pear Therapeutics executives start new VC firm

explore

fashion

focus

Cancer drug shortages should be causing more outrage

People can get long Covid without testing positive for virus: Study

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

Drug repurposing or repositioning? The language matters

Stem cell clinics for heart failure: buyer be wary

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

BioMarin wins approval for gene therapy to treat hemophilia A

TytoCare raises $49 million to build out AI

explore

Can U.S. cancer drug shortages be fixed?

Verily hires former Apple Health leader as chief scientific officer

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

California store owner shot dead in dispute over displaying Pride flag: Police

Meadows told special counsel he could not recall Trump ever declassifying Mar

ProMED, early warning system on disease outbreaks, in peril

knowledge

focus

hotspot

focus